Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Neurological Medicine
Volume 2016, Article ID 3431849, 3 pages
http://dx.doi.org/10.1155/2016/3431849
Case Report

Miller-Fisher Syndrome: Are Anti-GAD Antibodies Implicated in Its Pathophysiology?

3rd Department of Neurology, Medical School, Aristotle University of Thessaloniki, 57010 Thessaloniki, Greece

Received 13 March 2016; Accepted 11 April 2016

Academic Editor: Norman S. Litofsky

Copyright © 2016 Ioannis E. Dagklis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. W. Teener, “Miller Fisher's syndrome,” Seminars in Neurology, vol. 32, no. 5, pp. 512–516, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Shahrizaila and N. Yuki, “Bickerstaff brainstem encephalitis and Fisher syndrome: anti-GQ1b antibody syndrome,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 84, no. 5, pp. 576–583, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Koga, M. Gilbert, M. Takahashi et al., “GQ1b-seronegative Fisher syndrome: clinical features and new serological markers,” Journal of Neurology, vol. 259, no. 7, pp. 1366–1374, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Saiz, Y. Blanco, L. Sabater et al., “Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association,” Brain, vol. 131, part 10, pp. 2553–2563, 2008. View at Publisher · View at Google Scholar
  5. H. Alexopoulos and M. C. Dalakas, “Immunology of stiff person syndrome and other GAD-associated neurological disorders,” Expert Review of Clinical Immunology, vol. 9, no. 11, pp. 1043–1053, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. V. Pietrini, G. Pavesi, and F. Andreetta, “Miller Fisher syndrome with positivity of anti-GAD antibodies,” Clinical Neurology and Neurosurgery, vol. 115, no. 8, pp. 1479–1481, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Saltik, M. Türkeş, E. Tüzün, A. Cakir, and C. Ulusoy, “Peripheral neuropathy associated with antiglutamic acid decarboxylase antibodies,” Pediatric Neurology, vol. 48, no. 5, pp. 403–406, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Gupta and A. Liu, “Atypical Miller Fisher syndrome with anisocoria and rapidly fluctuating pupillary diameter,” Case Reports in Neurological Medicine, vol. 2015, Article ID 472843, 2 pages, 2015. View at Publisher · View at Google Scholar
  9. K. Nanri, H. Niwa, H. Mitoma et al., “Low-titer anti-GAD-antibody-positive cerebellar ataxia,” Cerebellum, vol. 12, no. 2, pp. 171–175, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Mitoma, K. Adhikari, D. Aeschlimann et al., “Consensus paper: neuroimmune mechanisms of cerebellar ataxias,” Cerebellum, vol. 15, no. 2, pp. 213–232, 2016. View at Publisher · View at Google Scholar
  11. T. Chang, H. Alexopoulos, P. Pettingill et al., “Immunization against GAD induces antibody binding to GAD-independent antigens and brainstem GABAergic neuronal loss,” PLoS ONE, vol. 8, no. 9, Article ID e72921, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Fouka, H. Alexopoulos, S. Akrivou, O. Trohatou, P. K. Politis, and M. C. Dalakas, “GAD65 epitope mapping and search for novel autoantibodies in GAD-associated neurological disorders,” Journal of Neuroimmunology, vol. 281, pp. 73–77, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Witschi, P. Punnakkal, J. Paul et al., “Presynaptic α2-GABAA receptors in primary afferent depolarization and spinal pain control,” The Journal of Neuroscience, vol. 31, no. 22, pp. 8134–8142, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Vianello, B. Tavolato, and B. Giometto, “Glutamic acid decarboxylase autoantibodies and neurological disorders,” Neurological Sciences, vol. 23, no. 4, pp. 145–151, 2002. View at Publisher · View at Google Scholar · View at Scopus